| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Hardware (& Manufacturing) • Material Science • DeepTech • Nanotechnology • Semiconductors |
| Stages | Seed, Series A, Series B, Series C, Pre-IPO |
| Investing | France |
| Investment Range | €1,000,000 - €20,000,000 |
Crédit Mutuel Innovation is a venture capital fund that focuses on accelerating the growth of innovative companies within the life sciences, digital technology, and deep technology sectors. They are committed to providing financial support ranging from EUR 1 million to EUR 20 million for businesses at various stages, from seed phase through to Series A, B, and C rounds, up to the pre-IPO stage.
Their operations are headquartered in Paris, France, at 29 Rue Saint-Augustin. Crédit Mutuel Innovation targets visionary entrepreneurs who demonstrate a strong potential for disruption and market leadership in their respective fields.
They leverage their extensive network and industry expertise to aid the companies in their portfolio, not just through funding but also by offering strategic guidance and access to a broader ecosystem.
This investor's strategic foresight is perhaps most evident in their emphasis on forward-looking industries, where emerging technologies and scientific advancements converge to produce transformative solutions and services.
Although traditionally risk-averse sectors such as life sciences and deep tech require substantive and patient capital, Crédit Mutuel Innovation positions itself as a steadfast partner for pioneering ventures set to shape the future of these industries. Their investment thesis wraps around the core belief that through meticulous selection and the nurturing of high-growth-potential enterprises, they can drive technological advancement and generate substantial returns.
Crédit Mutuel Innovation is an evergreen venture capital firm with €500 million of permanent capital and the VC subsidiairy of Crédit Mutuel Equity (€3.5 billion in capital, 350 portfolio companies).
What we look for: We invest in life science, digital and deeptech companies through Series A & B rounds with check size of €3m-€20m.
How we help: As an evergreen fund, we do not have a fixed end date and we have a solid capacity of reinvestment.Plus, we leverage the deapth of our portfolio: 300+ portfolio companies (including our PE activity).





